Special Issue "Enzyme Inhibitors of Marine Origin"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (28 February 2017)
Prof. Dr. Sadanandan E. Velu
Department of Chemistry, University of Alabama at Birmingham
Website | E-Mail
Phone: (205) 975 2478
Fax: +1 205 934 2543
Interests: organic/medicinal chemistry; drug discovery and development; anti-cancer and anti-infective agents; synthesis of marine natural products and their analogs; structure based drug design; SAR studies and lead optimization
Marine natural products have recently received increased attention as a source of lead compounds for drug discovery. These compounds are initially identified based on bioactivity screens and their mode of action is largely unknown. Discerning their mode of action is a critical step in their further development as potential drugs. Many of such lead compounds are enzyme inhibitors. This Special Issue focuses on such marine-derived natural products or their analogs that are enzyme inhibitors. The coverage includes the biological activities of the lead compounds, identification of the target enzyme, location of the enzyme binding site and the mechanistic details of the enzyme inhibition. We aim to publish both original research articles and review articles in this Special Issue.
Prof. Dr. Sadanandan E. Velu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine alkaloid
- enzyme inhibitor